Families involved in the Zofran (ondansetron) multidistrict litigation (“MDL”) alleged a 2016 label update for Zofran acknowledged for the first time that studies have shown an increased link between exposure to Zofran (ondansetron) and cardiovascular and cleft palate birth defects in babies born to women who took the drug while pregnant. However, the families contend...
Read moreZofran (ondansetron) MDL Judge Denies GlaxoSmithKline’s Request for Dismissal as Premature
In the latest development of the Zofran (ondansetron) multi-district litigation, GlaxoSmithKline’s request for dismissal of all claims were denied by Judge F. Dennis Saylor IV, the Massachusetts district judge presiding over the litigation. About 200 cases with similar claims were consolidated into the multidistrict litigation, or “MDL,” for the purpose of streamlining...
Bellwether Trial in Zimmer Duron Hip Replacement Litigation
On May 6, 2015, the first bellwether federal trial in the Zimmer Duron Cup hip replacement multi-district litigation commenced. The case will serve as a model for future litigation for the approximately 400 lawsuits pending against Zimmer, which all similarly allege that the Duron Cup hip replacement is defective and harmful to patients’ health, as...
Read moreStryker Hip Recipients Required to File Notice with Court on Revision Surgery
After thousands of Stryker Rejuvenate and ABG II metal-on-metal hip implants were recalled from the market in 2012 due to alarming failure rates and metallosis side effects, many recipients of the implant were required to undergo painful revision surgery to replace their defective hips. Over 5,000 patients sought litigation under a centralized multi-district litigation...
